Category: Latest News
-
SRM Entertainment Shares Climb on $100M TRON Treasury Initiative and Staking Milestone
SRM Entertainment (NASDAQ:SRM) shares gained 8% after the company announced it has successfully deployed over 365 million TRON (TRX) tokens into JustLend, a decentralized finance platform, as part of its broader $100 million TRON treasury strategy. The staking initiative enables SRM to earn an annualized yield of up to 10%, combining standard staking returns with…
-
Fortive Shares Dip After Finalizing Ralliant Spin-Off and Lowering Revenue Outlook
Fortive Corp (NYSE:FTV) saw its stock decline by 1.9% after completing the spin-off of its Precision Technologies business and issuing a cautionary update on second-quarter revenue performance. The industrial conglomerate confirmed the successful completion of its 100% spin-off of Ralliant Corporation, with shares of the new company now trading on the NYSE under the ticker…
-
Blaize Stock Jumps on $56 Million Edge AI Deployment in Southeast Asia
Blaize Holdings Inc (NASDAQ:BZAI) shares surged by 9.4% on Monday after the company announced it had secured a significant contract to roll out its edge AI technology across more than 250,000 smart surveillance endpoints throughout Southeast Asia. Valued at approximately $56 million, the contract is expected to generate $6 million in revenue during the second…
-
Google Signs Groundbreaking Fusion Energy Deal with Commonwealth Fusion Systems
Alphabet Inc.’s Google (NASDAQ:GOOGL) has entered into a landmark agreement to purchase electricity from a fusion power plant currently under development in Virginia, becoming the first corporation to secure a direct power purchase deal tied to commercial fusion energy. The agreement, announced Monday, involves 200 megawatts of electricity from Commonwealth Fusion Systems (CFS), a company…
-
NextNRG Shares Gain on Planned Acquisition of Canadian Fuel Logistics Firm
NextNRG Inc. (NASDAQ:NXXT) shares climbed 6.5% following the announcement of its intention to acquire ReFuel Mobile, a profitable mobile fueling provider based in Ontario, Canada. The deal, outlined in a non-binding letter of intent, would give NextNRG 100% ownership of ReFuel, with payment to be made either in cash or in restricted common shares, depending…
-
Joby Aviation Shares Climb After Successful Piloted Test Flights in Dubai
Joby Aviation, Inc. (NYSE:JOBY) saw its stock jump 6.75% after announcing the successful completion of piloted, wingborne vertical takeoff and landing (VTOL) flights in Dubai, a key step in the company’s path to launching commercial operations. The electric air taxi manufacturer delivered its first aircraft to the United Arab Emirates under a strategic collaboration with…
-
Avadel Stock Climbs as Appeals Court Backs FDA Approval of LUMRYZ
Shares of Avadel Pharmaceuticals PLC (NASDAQ:AVDL) rose 4.7% following a key legal victory, as a U.S. appeals court unanimously upheld the FDA’s approval of LUMRYZ, the company’s once-nightly treatment for narcolepsy. The decision marks a significant step forward in Avadel’s efforts to solidify its presence in the sleep disorder treatment space. The U.S. Court of…
-
BitMine Stock Skyrockets on $250M Private Placement to Back Ethereum Strategy
Shares of BitMine Immersion Technologies (AMEX:BMNR) surged 180% after the company unveiled a $250 million private placement aimed at executing a bold Ethereum-centric treasury strategy. The initiative could position BitMine among the largest publicly traded holders of Ethereum (ETH). The funding round includes the sale of 55,555,556 common shares priced at $4.50 each, targeting gross…
-
Moderna Shares Climb on Strong Phase 3 Results for Flu Vaccine Candidate
Moderna Inc (NASDAQ:MRNA) saw its stock rise 3.8% after announcing that its experimental flu vaccine, mRNA-1010, delivered positive results in a Phase 3 clinical trial, showing greater efficacy than standard influenza vaccines. In adults aged 50 and older, the mRNA-based vaccine candidate demonstrated a relative vaccine efficacy of 26.6% against influenza illness when compared to…
-
Rocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart Failure
Shares of Rocket Pharmaceuticals Inc (NASDAQ:RCKT) advanced 2.4% after the company announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for RP-A701, a gene therapy aimed at treating BAG3-associated Dilated Cardiomyopathy (DCM). The regulatory green light represents a major development for Rocket’s pipeline of cardiovascular gene therapies. RP-A701…